Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

British Journal of Haematology

Volumn 110, Issue 2, 2000, Pages 292-299

  Wardley, A M ^a   Jayson, G C ^a   Swindell, R ^a   Morgenstern, G R ^a   Chang, J ^a   Bloor, R ^a   Fraser, C J ^a   Scarffe, J H ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Mucositis; Transplantation

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW RESCUE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALGESICS, OPIOID; ANTINEOPLASTIC AGENTS, ALKYLATING; AREA UNDER CURVE; BONE MARROW TRANSPLANTATION; FEMALE; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MULTIVARIATE ANALYSIS; MYELOABLATIVE AGONISTS; PAIN; PROSPECTIVE STUDIES; STOMATITIS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033836189     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02202.x     Document Type: Article

References (29)

1. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study
2. Stomatologic complication of bone marrow transplantation in a pediatric population
3. Toxicities of total-body irradiation for pediatric bone marrow transplantation
4. High dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma
5. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
6. Oral complications in bone marrow transplant patients: Recent advances
7. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
8. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation
9. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy
10. Use of granulocyte colony stimulating factor to reduce the toxicity of super-VAC chemotherapy in advanced solid tumours in childhood
11. Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer
12. Effect of topical oral G-CSF on oral mucositis: A randomised placebo-controlled trial
13. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer
14. rhGM-CSF vs. placebo following rhGM-CSF-mobilized PBPC transplantation: A phase III double-blind randomized trial
15. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation
16. Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy
17. Reporting results in cancer patients
18. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial
19. Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines
20. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants
21. The impact of mucositis on α-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies
22. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index
23. The current status of toxicity protectants in cancer therapy
24. Oral mucositis in patients undergoing bone marrow transplantation
25. Prevention and management of oral mucositis induced by antineoplastic therapy
26. Oral complications in patients receiving treatment for malignancies other than that of head and neck
27. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia
28. The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients
29. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients